Effect of FGF-2 on survivin and subcellular location of Smac in human small cell lung cancer cell NCI-H446

Journal of Central South University (Medical Sciences)

Volumn 33, Issue 8, 2008, Pages 705-711

  Xiao, De Sheng ^a   Cao, Hui Qiu ^a   Deng, Zheng Hao ^a   Qu, Xiao Hui ^a   Wen, Ji Fang ^a   Zhou, Jian Hua ^a   Fu, Chun Yan ^a  

^a Central South University   (China)

Author keywords

Apoptosis; FGF 2; Smac; Small cell lung cancer; Survivin

Indexed keywords

BIRC5 PROTEIN, HUMAN; DIABLO PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 2; MICROTUBULE ASSOCIATED PROTEIN; MITOCHONDRIAL PROTEIN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CYTOPLASM; DRUG EFFECT; HUMAN; LUNG SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL CULTURE;

APOPTOSIS; CYTOPLASM; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; SMALL CELL LUNG CARCINOMA; TUMOR CELLS, CULTURED;

EID: 53649102977     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Yip D, Harper P G. Predictive and prognostic factors in small cell lung cancer: current status [J]. Lung Cancer, 2000, 28 (3): 173-185.
2. Lowe S W, Lin A W. Apoptosis in cancer [J]. Carcinogenesis, 2000, 21 (3): 485-495.
3. Okada B, Thiery J P, Jouanneau J. Fibroblast growth factor-2 [J]. Int J Biochem, 2000, 32 (3): 263-267.
4. Song S, Wientjes M, Gan Y, et al. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs [J]. Proc Natl Acad Sci USA, 2000, 97 (15): 8658-8663.
5. Giodini A, Kallio M J, Wall N R. Regulation of microtubule stability and mitotic progression by survivin [J]. Cancer Res, 2002, 62 (9): 2462-2467.
6. Shin S, Sung B J, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of Caspase-3 and Caspase-7 [J]. Biochemistry, 2001, 40 (4): 1117-1123.
7. Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c - dependent Caspase activation by eliminating IAP inhibition [J]. Cell, 2000, 102 (1): 33-42.
8. Verhagen A M, Ekert P G, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins [J]. Cell, 2000, 102 (1): 43-53.
9. Pardo O E, Lesay A, Arcaro A, et al. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells [J]. Mol Cell Biol, 2003, 23 (21): 7600-7610.
10. Wang K S, Hu ZL, Li J H, et al. Enhancement of metastatic and invasive capacity of gastric cancer cells by transforming growth factor-beta1 [J]. Acta Biochim Biophys Sin, 2006, 38 (3): 179-186.
11. Altieri D C. Validating survivin as a cancer therapeutic target [J]. Nat Rev Cancer, 2003, 3 (1): 46-54.
12. Kuhn H, Kopff C, Konrad J, et al. Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines [J]. Lung Cancer, 2004, 44 (2): 167-174.
13. Madiai F, Goettl V M, Hussian SR, et al. Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain [J]. J Mol Neurosci, 2005, 27 (3): 315-324.
14. Dailey L, Ambrosetti D, Mansukhani A, et al. Mechanisms underlying differential responses to FGF signaling [J]. Cytokine Growth Factor Rev, 2005, 16 (2): 233-247.
15. Verdecia M, Huang H, Dutil E, et al. Structure of the human anti-apoptotic protein reveals a dimeric arrangement [J]. Nat Strit Biol, 2000, 7 (7): 602-608.
16. McNeish I A, Bell S, McKay T, et al. Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a Caspase-9-mediated pathway [J]. Exp Cell Res, 2003, 286 (2): 186-198.
17. Kipp R A, Case M A, Wist A D, et al. Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners [J]. Biochemistry, 2002, 41 (23): 7344-7349.
18. Yang L, Mashima T, Sato S, et al. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide [J]. Cancer Res, 2003, 63 (4): 831-837.